Hard Drive Savers Inc

Incorporated in 1993, Hard to Treat Diseases is a publicly traded holding company involved in the development and licensing of proprietary technologies. It is engaged in the enhancement and modification of various drugs for the treatment of hepatitis C, multiple sclerosis, HIV and central nervous system damage. The company operates Shenzhen Mellow Hope Pharm Industrial Company, which is a wholly owned subsidiary and is one of the largest exporters of biological vaccines in China. Shenzhen Mellow Hope Pharm Industrial Company provides vaccines for the treatment of poliomyelitis, influenza and meningococcal. Hard to Treat Diseases additionally operates a subsidiary, Slavica Biochem, which offers research solutions for the development of anticancer drugs. The parent company has a staff of more than 40 employees, as well as has received the Nikola Tesla award.